Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

Sangamo Therapeutics, a genomic medicine company (NASDAQ: SGMO), will participate in three upcoming investor conferences in March 2022. These include the Cowen 42nd Annual Health Care Conference on March 7 at 12:50 p.m. ET, the Barclays Global Healthcare Conference on March 17 at 9:00 a.m. ET, and the H.C. Wainwright & Co. Gene Editing and Therapy Conference on March 30 at 7:00 a.m. ET. Presentations will be accessible via the company’s website in the Investors and Media section post-event.

For more details about Sangamo's innovative genomic medicines pipeline, visit www.sangamo.com.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

• Cowen 42^nd Annual Health Care Conference
  Date: Monday, March 7^th at 12:50 p.m. Eastern Time

• Barclays Global Healthcare Conference
  Date: Thursday, March 17^th at 9:00 a.m. Eastern Time

• H.C. Wainwright & Co. Gene Editing and Therapy Conference 2022
  Date: Wednesday, March 30^th at 7:00 a.m. Eastern Time

Access links for presentations, panels and fireside chats will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005783/en/

Investor Relations & Media Inquiries

Aron Feingold

628.252.7494

afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

What is the schedule for Sangamo Therapeutics at the Cowen 42nd Annual Health Care Conference?

Sangamo Therapeutics will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022, at 12:50 p.m. Eastern Time.

When will Sangamo Therapeutics attend the Barclays Global Healthcare Conference?

Sangamo Therapeutics is set to participate in the Barclays Global Healthcare Conference on March 17, 2022, at 9:00 a.m. Eastern Time.

What details are available for the H.C. Wainwright & Co. Gene Editing and Therapy Conference involving SGMO?

Sangamo Therapeutics will be at the H.C. Wainwright & Co. Gene Editing and Therapy Conference on March 30, 2022, at 7:00 a.m. Eastern Time.

Where can I find presentations from Sangamo Therapeutics' investor conferences?

Presentations from Sangamo Therapeutics' investor conferences will be available on their website in the Investors and Media section after the events.

What is the focus of Sangamo Therapeutics' genomic medicines pipeline?

Sangamo Therapeutics focuses on developing genomic medicines using proprietary zinc finger genome engineering technology for diseases with inadequate treatment options.